These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 21663987)
21. T Cell Receptor Engineered Lymphocytes for Cancer Therapy. Rollins MR; Spartz EJ; Stromnes IM Curr Protoc Immunol; 2020 Jun; 129(1):e97. PubMed ID: 32432843 [TBL] [Abstract][Full Text] [Related]
22. Current strategies to improve the safety of chimeric antigen receptor (CAR) modified T cells. Yang QY; Yang JD; Wang YS Immunol Lett; 2017 Oct; 190():201-205. PubMed ID: 28837818 [TBL] [Abstract][Full Text] [Related]
23. Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors. Front Immunol; ; . PubMed ID: 29872437 [TBL] [Abstract][Full Text] [Related]